FEMY News & Events

Femasys announced a new strategic distribution partnership with OR Consulting to support the commercial launch of its product portfolio in Switzerland. The agreement includes FemBloc Permanent Birth Control, FemaSeed Intratubal Insemination, and additional Femasys fertility and women's diagnostic health products. Together with the Company's recent market entry in Spain and the ongoing commercial launch in France, this partnership represents continued execution of Femasys' European expansion strategy and broadens access to its innovative technologies through experienced regional partners.

Femasys announced a partnership with Refuah Health Center to offer FemaSeed as a first step in the infertility treatment process. "This partnership is an important step forward in expanding the commercial availability of FemaSeed within community-based fertility care," said Kathy Lee-Sepsick, Chief Executive Officer of Femasys. "With Refuah's trusted care model and strong patient engagement, we expect to accelerate adoption of FemaSeed by providing a more accessible, cost-effective, and patient-centered starting point for fertility treatment."

Femasys files to sell 68.42M shares of common stock for holders